Who invested in NeuroLutions

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$28Mraised across 2 rounds since 2015, from 2 sources

$1.1MVenture$27MVenture

Latest round: Venture, $27MMar 2025
Step-upi: 23×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201520172019202120232025

$1.1MVenture$27MVenture

First round: Venture, $1.1M
Biggest round: $27M
Between rounds: 9.8 years

The rounds

Mar 2025
Venture$27M1 new
- Ascension
Source recordedSEC filing: $27M sold, first sale Feb 2025
Jun 2015
Venture$1.1M3 new
From a historical funding record

Founders and team

From NeuroLutions's own website: 12 on the team.

Leo PetrossianChief Executive Officer
Andy SchultzChief Commercial Officer
Javad SeyedzadehChief Operations Officer
Kirsten CarrollChief Marketing Officer
Nabeel AhmedChief Financial Officer
Seth WilkChief Innovation Officer
Bret ChristensenBoard Member
Fred KhosraviChairman of the Board
Kevin ReillyBoard Member
Marshal LinderBoard Member
Michael LevitzBoard Member
William TaiBoard Member

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2015Venture2025

Everyone who backed them

AscensionVC firm1round

Ascension VenturesCorporate VC1round

Prolog VenturesVC firm1round

BioGeneratorVenture studio1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list NeuroLutions as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.